共 50 条
- [1] Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma not progressed with first-line chemotherapy: Prespecified subgroup analyses from JAVELIN Bladder 100[J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 126 - 126Lumba, Sumit论文数: 0 引用数: 0 h-index: 0机构: Royal North Shore Hosp, Sydney, NSW, Australia Royal North Shore Hosp, Sydney, NSW, AustraliaGrivas, Petros论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Seattle, WA 98195 USA Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Clin Res Div, 1124 Columbia St, Seattle, WA 98104 USA Royal North Shore Hosp, Sydney, NSW, AustraliaPark, Se Hoon论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea Royal North Shore Hosp, Sydney, NSW, AustraliaVoog, Eric论文数: 0 引用数: 0 h-index: 0机构: Ctr Jean Bernard Clin Victor Hugo, Le Mans, France Royal North Shore Hosp, Sydney, NSW, AustraliaCaserta, Claudia论文数: 0 引用数: 0 h-index: 0机构: Azienda Osped S Maria, Med Oncol Unit, Terni, Italy Royal North Shore Hosp, Sydney, NSW, AustraliaValderrama, Begona P.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen Rocio, Seville, Spain Royal North Shore Hosp, Sydney, NSW, Australia论文数: 引用数: h-index:机构:Kalofonos, Haralabos论文数: 0 引用数: 0 h-index: 0机构: Univ Gen Hosp Patras, Med Oncol, Patras, Greece Royal North Shore Hosp, Sydney, NSW, AustraliaRadulovic, Sinisa论文数: 0 引用数: 0 h-index: 0机构: Inst Oncol & Radiol Serbia, Belgrade, Serbia Royal North Shore Hosp, Sydney, NSW, AustraliaDemey, Wim论文数: 0 引用数: 0 h-index: 0机构: AZ KLINA, Brasschaat, Belgium Royal North Shore Hosp, Sydney, NSW, AustraliaUllen, Anders论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp, Genitourinary Oncol Unit, Solna, Sweden Royal North Shore Hosp, Sydney, NSW, AustraliaLoriot, Yohann论文数: 0 引用数: 0 h-index: 0机构: Univ Paris Saclay, Gustave Roussy, INSERM, U981, Villejuif, France Royal North Shore Hosp, Sydney, NSW, AustraliaSridhar, Srikala S.论文数: 0 引用数: 0 h-index: 0机构: Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada Royal North Shore Hosp, Sydney, NSW, AustraliaTsuchiya, Norihiko论文数: 0 引用数: 0 h-index: 0机构: Yamagata Univ, Fac Med, Yamagata, Japan Royal North Shore Hosp, Sydney, NSW, AustraliaKopyltsov, Evgeny论文数: 0 引用数: 0 h-index: 0机构: State Inst Healthcare Reg Clin Oncol Dispensary, Omsk, Russia Royal North Shore Hosp, Sydney, NSW, AustraliaGupta, Shilpa论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin, Cleveland, OH 44106 USA Royal North Shore Hosp, Sydney, NSW, AustraliaHuang, Bo论文数: 0 引用数: 0 h-index: 0机构: Pfizer, Groton, CT USA Royal North Shore Hosp, Sydney, NSW, AustraliaCosta, Nuno论文数: 0 引用数: 0 h-index: 0机构: Pfizer, Porto Salvo, Portugal Royal North Shore Hosp, Sydney, NSW, AustraliaBlake-Haskins, John A.论文数: 0 引用数: 0 h-index: 0机构: Pfizer, La Jolla, CA USA Royal North Shore Hosp, Sydney, NSW, Australiadi Pietro, Alessandra论文数: 0 引用数: 0 h-index: 0机构: Pfizer Srl, Milan, Italy Royal North Shore Hosp, Sydney, NSW, AustraliaPowles, Thomas论文数: 0 引用数: 0 h-index: 0机构: Queen Mary Univ London, St Bartholomews Hosp, Expt Canc Med Ctr, Barts Canc Inst, London, England Royal North Shore Hosp, Sydney, NSW, Australia
- [2] Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma: JAVELIN Bladder 100 subgroup analysis based on duration and cycles of first-line chemotherapy[J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 46 - 46论文数: 引用数: h-index:机构:Loriot, Yohann论文数: 0 引用数: 0 h-index: 0机构: Univ Paris Saclay, Gustave Roussy, INSERM, U981, Villejuif, France Macquarie Univ, Sydney, NSW, AustraliaPowles, Thomas论文数: 0 引用数: 0 h-index: 0机构: Queen Mary Univ London, St Bartholomews Hosp, Expt Canc Med Ctr, Barts Canc Inst, London, England Macquarie Univ, Sydney, NSW, AustraliaDuran, Climent Miguel论文数: 0 引用数: 0 h-index: 0机构: Inst Valenciano Oncol, Valencia, Spain Macquarie Univ, Sydney, NSW, AustraliaSridhar, Srikala论文数: 0 引用数: 0 h-index: 0机构: Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada Macquarie Univ, Sydney, NSW, AustraliaBellmunt, Joaquim论文数: 0 引用数: 0 h-index: 0机构: Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA Harvard Med Sch, Boston, MA 02115 USA Macquarie Univ, Sydney, NSW, AustraliaPetrylak, Daniel论文数: 0 引用数: 0 h-index: 0机构: Yale Canc Ctr, New Haven, CT USA Macquarie Univ, Sydney, NSW, AustraliaWang, Jing论文数: 0 引用数: 0 h-index: 0机构: Pfizer, Cambridge, MA USA Macquarie Univ, Sydney, NSW, AustraliaCosta, Nuno论文数: 0 引用数: 0 h-index: 0机构: Pfizer, Porto Salvo, Portugal Macquarie Univ, Sydney, NSW, AustraliaLaliberte, Robert论文数: 0 引用数: 0 h-index: 0机构: Pfizer, Cambridge, MA USA Macquarie Univ, Sydney, NSW, AustraliaDi Pietro, Alessandra论文数: 0 引用数: 0 h-index: 0机构: Pfizer Srl, Milan, Italy Macquarie Univ, Sydney, NSW, AustraliaGrivas, Petros论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USA Macquarie Univ, Sydney, NSW, AustraliaSternberg, Cora论文数: 0 引用数: 0 h-index: 0机构: Weill Cornell Med, Englander Inst Precis Med, Hematol Oncol, New York, NY USA Macquarie Univ, Sydney, NSW, Australia
- [3] Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma: JAVELIN Bladder 100 subgroup analysis based on duration and cycles of first-line chemotherapy[J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 132 - 133Powles, Thomas论文数: 0 引用数: 0 h-index: 0机构: Queen Mary Univ London, Barts Canc Inst, St Bartholomews Hosp, Expt Canc Med Ctr, London, England Queen Mary Univ London, Barts Canc Inst, St Bartholomews Hosp, Expt Canc Med Ctr, London, EnglandLoriot, Yohann论文数: 0 引用数: 0 h-index: 0机构: Univ Paris Saclay, Gustave Roussy, INSERM, U981, Villejuif, France Queen Mary Univ London, Barts Canc Inst, St Bartholomews Hosp, Expt Canc Med Ctr, London, EnglandDuran, Miguel A. Climent论文数: 0 引用数: 0 h-index: 0机构: Inst Valenciano Oncol, Valencia, Spain Queen Mary Univ London, Barts Canc Inst, St Bartholomews Hosp, Expt Canc Med Ctr, London, EnglandSridhar, Srikala论文数: 0 引用数: 0 h-index: 0机构: Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada Queen Mary Univ London, Barts Canc Inst, St Bartholomews Hosp, Expt Canc Med Ctr, London, EnglandBellmunt, Joaquim论文数: 0 引用数: 0 h-index: 0机构: Beth Israel Deaconess Med Ctr, Boston, MA USA Queen Mary Univ London, Barts Canc Inst, St Bartholomews Hosp, Expt Canc Med Ctr, London, EnglandPetrylak, Daniel P.论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Boston, MA 02115 USA Queen Mary Univ London, Barts Canc Inst, St Bartholomews Hosp, Expt Canc Med Ctr, London, EnglandWang, Jing论文数: 0 引用数: 0 h-index: 0机构: Yale Canc Ctr, New Haven, CT USA Queen Mary Univ London, Barts Canc Inst, St Bartholomews Hosp, Expt Canc Med Ctr, London, EnglandCosta, Nuno论文数: 0 引用数: 0 h-index: 0机构: Pfizer, Cambridge, MA USA Queen Mary Univ London, Barts Canc Inst, St Bartholomews Hosp, Expt Canc Med Ctr, London, EnglandLaliberte, Robert论文数: 0 引用数: 0 h-index: 0机构: Pfizer, Porto, Portugal Queen Mary Univ London, Barts Canc Inst, St Bartholomews Hosp, Expt Canc Med Ctr, London, Englanddi Pietro, Alessandra论文数: 0 引用数: 0 h-index: 0机构: Pfizer Srl, Milan, Italy Univ Washington, Seattle, WA USA Queen Mary Univ London, Barts Canc Inst, St Bartholomews Hosp, Expt Canc Med Ctr, London, EnglandGrivas, Petros论文数: 0 引用数: 0 h-index: 0机构: Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Clin Res Div, Washington, DC USA Queen Mary Univ London, Barts Canc Inst, St Bartholomews Hosp, Expt Canc Med Ctr, London, EnglandSternberg, Cora N.论文数: 0 引用数: 0 h-index: 0机构: Weill Cornell Med, Hematol Oncol, Englander Inst Precis Med, New York, NY USA Queen Mary Univ London, Barts Canc Inst, St Bartholomews Hosp, Expt Canc Med Ctr, London, England
- [4] Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis[J]. International Journal of Clinical Oncology, 2022, 27 : 383 - 395Yoshihiko Tomita论文数: 0 引用数: 0 h-index: 0机构: Niigata University Graduate School of Medicine,Department of Urology and Department of Molecular OncologyYoshiaki Yamamoto论文数: 0 引用数: 0 h-index: 0机构: Niigata University Graduate School of Medicine,Department of Urology and Department of Molecular OncologyNorihiko Tsuchiya论文数: 0 引用数: 0 h-index: 0机构: Niigata University Graduate School of Medicine,Department of Urology and Department of Molecular OncologyHiroomi Kanayama论文数: 0 引用数: 0 h-index: 0机构: Niigata University Graduate School of Medicine,Department of Urology and Department of Molecular OncologyMasatoshi Eto论文数: 0 引用数: 0 h-index: 0机构: Niigata University Graduate School of Medicine,Department of Urology and Department of Molecular OncologyHideaki Miyake论文数: 0 引用数: 0 h-index: 0机构: Niigata University Graduate School of Medicine,Department of Urology and Department of Molecular OncologyThomas Powles论文数: 0 引用数: 0 h-index: 0机构: Niigata University Graduate School of Medicine,Department of Urology and Department of Molecular OncologyMizuki Yoshida论文数: 0 引用数: 0 h-index: 0机构: Niigata University Graduate School of Medicine,Department of Urology and Department of Molecular OncologyYuichiro Koide论文数: 0 引用数: 0 h-index: 0机构: Niigata University Graduate School of Medicine,Department of Urology and Department of Molecular OncologyYoshiko Umeyama论文数: 0 引用数: 0 h-index: 0机构: Niigata University Graduate School of Medicine,Department of Urology and Department of Molecular OncologyAlessandra di Pietro论文数: 0 引用数: 0 h-index: 0机构: Niigata University Graduate School of Medicine,Department of Urology and Department of Molecular OncologyHirotsugu Uemura论文数: 0 引用数: 0 h-index: 0机构: Niigata University Graduate School of Medicine,Department of Urology and Department of Molecular Oncology
- [5] Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis[J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (02) : 383 - 395Tomita, Yoshihiko论文数: 0 引用数: 0 h-index: 0机构: Niigata Univ, Dept Urol, Grad Sch Med, Chuou Ku, 1-757 Asahimachi, Niigata 9518510, Japan Niigata Univ, Dept Mol Oncol, Grad Sch Med, Chuou Ku, 1-757 Asahimachi, Niigata 9518510, Japan Niigata Univ, Dept Urol, Grad Sch Med, Chuou Ku, 1-757 Asahimachi, Niigata 9518510, JapanYamamoto, Yoshiaki论文数: 0 引用数: 0 h-index: 0机构: Yamaguchi Univ, Grad Sch Med, Dept Urol, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan Niigata Univ, Dept Urol, Grad Sch Med, Chuou Ku, 1-757 Asahimachi, Niigata 9518510, JapanTsuchiya, Norihiko论文数: 0 引用数: 0 h-index: 0机构: Yamagata Univ, Dept Urol, Fac Med, 2-2-2 Iida Nishi, Yamagata 9909585, Japan Niigata Univ, Dept Urol, Grad Sch Med, Chuou Ku, 1-757 Asahimachi, Niigata 9518510, JapanKanayama, Hiroomi论文数: 0 引用数: 0 h-index: 0机构: Tokushima Univ, Dept Urol, Grad Sch Biomed Sci, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan Niigata Univ, Dept Urol, Grad Sch Med, Chuou Ku, 1-757 Asahimachi, Niigata 9518510, Japan论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Powles, Thomas论文数: 0 引用数: 0 h-index: 0机构: Queen Mary Univ London, Expt Canc Med Ctr, Barts Canc Inst, St Bartholomews Hosp, London EC1A 7BE, England Niigata Univ, Dept Urol, Grad Sch Med, Chuou Ku, 1-757 Asahimachi, Niigata 9518510, JapanYoshida, Mizuki论文数: 0 引用数: 0 h-index: 0机构: Pfizer R&D Japan, Shibuya Ku, 3-22-7 Yoyogi, Tokyo 1518589, Japan Niigata Univ, Dept Urol, Grad Sch Med, Chuou Ku, 1-757 Asahimachi, Niigata 9518510, JapanKoide, Yuichiro论文数: 0 引用数: 0 h-index: 0机构: Pfizer R&D Japan, Shibuya Ku, 3-22-7 Yoyogi, Tokyo 1518589, Japan Niigata Univ, Dept Urol, Grad Sch Med, Chuou Ku, 1-757 Asahimachi, Niigata 9518510, JapanUmeyama, Yoshiko论文数: 0 引用数: 0 h-index: 0机构: Pfizer R&D Japan, Shibuya Ku, 3-22-7 Yoyogi, Tokyo 1518589, Japan Niigata Univ, Dept Urol, Grad Sch Med, Chuou Ku, 1-757 Asahimachi, Niigata 9518510, Japandi Pietro, Alessandra论文数: 0 引用数: 0 h-index: 0机构: Pfizer Srl, Via Anna Maria Mozzoni 12, I-20152 Milan, Italy Niigata Univ, Dept Urol, Grad Sch Med, Chuou Ku, 1-757 Asahimachi, Niigata 9518510, JapanUemura, Hirotsugu论文数: 0 引用数: 0 h-index: 0机构: Kindai Univ, Fac Med, Dept Urol, 377-2 Ohno Higashi, Osakasayama, Osaka 5898511, Japan Niigata Univ, Dept Urol, Grad Sch Med, Chuou Ku, 1-757 Asahimachi, Niigata 9518510, Japan
- [6] Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma: analysis of time to end of next-line therapy in JAVELIN Bladder 100[J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 45 - 45Grivas, Petros论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USA Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USAPark, Se Hoon论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USAVoog, Eric论文数: 0 引用数: 0 h-index: 0机构: Ctr Jean Bernard Clin Victor Hugo, Le Mans, France Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USAKopyltsov, Evgeny论文数: 0 引用数: 0 h-index: 0机构: State Inst Healthcare Reg Clin Oncol Dispensary, Omsk, Russia Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USAGurney, Howard论文数: 0 引用数: 0 h-index: 0机构: Macquarie Univ, Dept Clin Med, Sydney, NSW, Australia Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USAMuniz, Queiroz Borges David论文数: 0 引用数: 0 h-index: 0机构: Inst Canc Estado Sao Paulo ICESP, Fundacao Fac Med, Sao Paulo, Brazil Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USARolland, Frederic论文数: 0 引用数: 0 h-index: 0机构: Inst Cancerol Ouest, Nantes, France Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USAAls, Anne Birgitte论文数: 0 引用数: 0 h-index: 0机构: Aarhus Univ Hosp, Aarhus, Denmark Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USAValderrama, Begona论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen Rocio, Dept Med Oncol, Seville, Spain Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USAWang, Jing论文数: 0 引用数: 0 h-index: 0机构: Pfizer, Cambridge, MA USA Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USACosta, Nuno论文数: 0 引用数: 0 h-index: 0机构: Pfizer, Porto Salvo, Portugal Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USALaliberte, Robert论文数: 0 引用数: 0 h-index: 0机构: Pfizer, Cambridge, MA USA Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USAdi Pietro, Alessandra论文数: 0 引用数: 0 h-index: 0机构: Pfizer Srl, Milan, Italy Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USAPowles, Thomas论文数: 0 引用数: 0 h-index: 0机构: Queen Mary Univ London, St Bartholomews Hosp, Expt Canc Med Ctr, Barts Canc Inst, London, England Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USABellmunt, Joaquim论文数: 0 引用数: 0 h-index: 0机构: Beth Israel Deaconess Med Ctr, Dept Med Oncol, Boston, MA 02215 USA Harvard Med Sch, Boston, MA 02115 USA Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USA
- [7] AVELUMAB FIRST-LINE MAINTENANCE PLUS BEST SUPPORTIVE CARE VS BEST SUPPORTIVE CARE ALONE FOR ADVANCED UROTHELIAL CARCINOMA: ANALYSIS OF TIME TO END OF NEXT-LINE THERAPY IN JAVELIN BLADDER 100[J]. JOURNAL OF UROLOGY, 2021, 206 : E765 - E765Grivas, Petros论文数: 0 引用数: 0 h-index: 0Park, Se Hoon论文数: 0 引用数: 0 h-index: 0Voog, Eric论文数: 0 引用数: 0 h-index: 0Kopyltsov, Evgeny论文数: 0 引用数: 0 h-index: 0Gurney, Howard论文数: 0 引用数: 0 h-index: 0Borges Muniz, David Queiroz论文数: 0 引用数: 0 h-index: 0Rolland, Frederic论文数: 0 引用数: 0 h-index: 0Als, Anne Birgitte论文数: 0 引用数: 0 h-index: 0Valderrama, Begona P.论文数: 0 引用数: 0 h-index: 0Wang, Jing论文数: 0 引用数: 0 h-index: 0Costa, Nuno论文数: 0 引用数: 0 h-index: 0Laliberte, Robert J.论文数: 0 引用数: 0 h-index: 0di Pietro, Alessandra论文数: 0 引用数: 0 h-index: 0Powles, Thomas论文数: 0 引用数: 0 h-index: 0Bellmunt, Joaquim论文数: 0 引用数: 0 h-index: 0
- [8] Patient-reported Outcomes from JAVELIN Bladder 100: Avelumab First-line Maintenance Plus Best Supportive Care Versus Best Supportive Care Alone for Advanced Urothelial Carcinoma[J]. EUROPEAN UROLOGY, 2023, 83 (04) : 320 - 328Grivas, Petros论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USA Fred Hutchinson Canc Res Ctr, Clin Res Div, Seattle Canc Care Alliance, Seattle, WA 98109 USA Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USAKopyltsov, Evgeny论文数: 0 引用数: 0 h-index: 0机构: State Inst Healthcare Reg Clin Oncol Dispensary, Omsk, Russia Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USASu, Po-Jung论文数: 0 引用数: 0 h-index: 0机构: Chang Gung Mem Hosp, LinKuo, Taiwan Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USAParnis, Francis X.论文数: 0 引用数: 0 h-index: 0机构: Univ Adelaide, Adelaide Canc Ctr, Adelaide, Australia Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USAPark, Se Hoon论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USAYamamoto, Yoshiaki论文数: 0 引用数: 0 h-index: 0机构: Yamaguchi Univ, Ube, Yamaguchi, Japan Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USAFong, Peter C.论文数: 0 引用数: 0 h-index: 0机构: Univ Auckland, Auckland City Hosp, Auckland, New Zealand Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USATournigand, Christophe论文数: 0 引用数: 0 h-index: 0机构: Paris Est Creteil Univ, Hop Henri Mondor, Assistance Publ Hop Paris, Creteil, Paris, France Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USADuran, Miguel A. Climent论文数: 0 引用数: 0 h-index: 0机构: Inst Valenciano Oncol, Valencia, Spain Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USABamias, Aristotelis论文数: 0 引用数: 0 h-index: 0机构: Natl & Kapodistrian Univ Athens, Alexandra Gen Hosp, Sch Med, Athens, Greece Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USACaserta, Claudia论文数: 0 引用数: 0 h-index: 0机构: Azienda Ospedaliera S Maria, Med Oncol Unit, Terni, Italy Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USAChang, Jane论文数: 0 引用数: 0 h-index: 0机构: Pfizer, New York, NY USA Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USACislo, Paul论文数: 0 引用数: 0 h-index: 0机构: Pfizer, New York, NY USA Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USAdi Pietro, Alessandra论文数: 0 引用数: 0 h-index: 0机构: Pfizer srl, Milan, Italy Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USAWang, Jing论文数: 0 引用数: 0 h-index: 0机构: Pfizer, Cambridge, MA USA Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USAPowles, Thomas论文数: 0 引用数: 0 h-index: 0机构: Queen Mary Univ London, St Bartholomews Hosp, Barts Canc Inst, Expt Canc Med Ctr, London, England Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USA
- [9] Avelumab first-line maintenance plus best supportive care (BSC) vs. BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Asian subgroup analysis[J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (05) : 256.e17 - 256.e25Lee, Jae-Lyun论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaDesai, Chirag论文数: 0 引用数: 0 h-index: 0机构: Hemato Oncol Clin Pvt A Ltd, HOC Vedanta, Ahmadabad, India Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaPark, Se Hoon论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Seoul, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaTsuchiya, Norihiko论文数: 0 引用数: 0 h-index: 0机构: Yamagata Univ, Fac Med, Dept Urol, Yamagata, Japan Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaSu, Po-Jung论文数: 0 引用数: 0 h-index: 0机构: Chang Gung Mem Hosp Linkou, Dept Internal Med, Div Hematol Oncol, Taoyuan City, Taiwan Chang Gung Univ, Coll Med, Taoyuan, Taiwan Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaChan, Timothy Tim Wai论文数: 0 引用数: 0 h-index: 0机构: Queen Elizabeth Hosp, Dept Clin Oncol, Kowloon, Hong Kong, Peoples R China Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaGurney, Howard论文数: 0 引用数: 0 h-index: 0机构: Macquarie Univ, Dept Clin Med, Sydney, Australia Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaGao, Seasea论文数: 0 引用数: 0 h-index: 0机构: Merck Pte Ltd, Singapore, Singapore Merck KGaA, Darmstadt, Germany Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaWang, Jing论文数: 0 引用数: 0 h-index: 0机构: Pfizer, Cambridge, MA USA Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaSandner, Robin论文数: 0 引用数: 0 h-index: 0机构: Pfizer, Collegeville, PA USA Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Koreadi Pietro, Alessandra论文数: 0 引用数: 0 h-index: 0机构: Pfizer srl, Milan, Italy Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea论文数: 引用数: h-index:机构:
- [10] Avelumab first-line (1L) maintenance plus best supportive care (BSC) vs BSC alone with 1L chemotherapy (CTx) for advanced urothelial carcinoma (UC): Subgroup analyses from JAVELIN Bladder 100[J]. ANNALS OF ONCOLOGY, 2020, 31 : S555 - S556Grivas, P.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Div Med Oncol, Dept Med, Seattle, WA 98195 USA Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA Univ Washington, Div Med Oncol, Dept Med, Seattle, WA 98195 USAPark, S. H.论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Samsung Med Ctr, Dept Internal Med, Div Hematol Oncol, Seoul, South Korea Univ Washington, Div Med Oncol, Dept Med, Seattle, WA 98195 USAVoog, E.论文数: 0 引用数: 0 h-index: 0机构: Ctr Jean Bernard Clin Victor Hugo, Dept Med Oncol, Le Mans, France Univ Washington, Div Med Oncol, Dept Med, Seattle, WA 98195 USACaserta, C.论文数: 0 引用数: 0 h-index: 0机构: Azienda Osped S Maria, Med Oncol Unit, Terni, Italy Univ Washington, Div Med Oncol, Dept Med, Seattle, WA 98195 USAPerez Valderrama, B.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen del Rocio, Dept Med Oncol, Seville, Spain Univ Washington, Div Med Oncol, Dept Med, Seattle, WA 98195 USAGurney, H.论文数: 0 引用数: 0 h-index: 0机构: Macquarie Univ, Dept Clin Med, Sydney, NSW, Australia Univ Washington, Div Med Oncol, Dept Med, Seattle, WA 98195 USAKalofonos, H.论文数: 0 引用数: 0 h-index: 0机构: Univ Gen Hosp Patras, Med Oncol, Patras, Greece Univ Washington, Div Med Oncol, Dept Med, Seattle, WA 98195 USARadulovic, S.论文数: 0 引用数: 0 h-index: 0机构: Inst Oncol & Radiol Serbia, Dept Med Oncol, Belgrade, Serbia Univ Washington, Div Med Oncol, Dept Med, Seattle, WA 98195 USADemey, W.论文数: 0 引用数: 0 h-index: 0机构: AZ Klina, Dept Med Oncol, Brasschaat, Belgium Univ Washington, Div Med Oncol, Dept Med, Seattle, WA 98195 USAUllen, A.论文数: 0 引用数: 0 h-index: 0机构: Karolinska Inst, Karolinska Univ Hosp, Dept Oncol Pathol, Solna, Sweden Univ Washington, Div Med Oncol, Dept Med, Seattle, WA 98195 USALoriot, Y.论文数: 0 引用数: 0 h-index: 0机构: Univ Paris Saclay, Inst Gustave Roussy, Dept Med Oncol, INSERM,U981, Villejuif, France Univ Washington, Div Med Oncol, Dept Med, Seattle, WA 98195 USASridhar, S. S.论文数: 0 引用数: 0 h-index: 0机构: Univ Hlth Network, Princess Margaret Canc Ctr, Dept Med, Toronto, ON, Canada Univ Washington, Div Med Oncol, Dept Med, Seattle, WA 98195 USATsuchiya, N.论文数: 0 引用数: 0 h-index: 0机构: Yamagata Univ, Dept Urol, Fac Med, Yamagata, Japan Univ Washington, Div Med Oncol, Dept Med, Seattle, WA 98195 USAKopyltsov, E.论文数: 0 引用数: 0 h-index: 0机构: State Inst Healthcare Reg Clin Oncol Dispensary, Dept Med Oncol, Omsk, Russia Univ Washington, Div Med Oncol, Dept Med, Seattle, WA 98195 USAGupta, S.论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA Univ Washington, Div Med Oncol, Dept Med, Seattle, WA 98195 USAHuang, B.论文数: 0 引用数: 0 h-index: 0机构: Pfizer, Biostat, Groton, CT USA Univ Washington, Div Med Oncol, Dept Med, Seattle, WA 98195 USACosta, N.论文数: 0 引用数: 0 h-index: 0机构: Pfizer, Global Oncol, Lisbon, Portugal Univ Washington, Div Med Oncol, Dept Med, Seattle, WA 98195 USABlake-Haskins, J. A.论文数: 0 引用数: 0 h-index: 0机构: Pfizer, Immunooncol, La Jolla, CA USA Univ Washington, Div Med Oncol, Dept Med, Seattle, WA 98195 USAdi Pietro, A.论文数: 0 引用数: 0 h-index: 0机构: Pfizer SRL, Immunooncol, Milan, Italy Univ Washington, Div Med Oncol, Dept Med, Seattle, WA 98195 USAPowles, T. B.论文数: 0 引用数: 0 h-index: 0机构: Queen Mary Univ London, St Bartholomews Hosp, Expt Canc Med Ctr, Dept Med Oncol,Barts Canc Inst, London, England Univ Washington, Div Med Oncol, Dept Med, Seattle, WA 98195 USA